Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MANBA | O00462 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28229704 | 1.00 | LMNA (0.50) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL24037211 | 1.00 | LMNA (0.50) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL15827805 | 0.79 | LMNA (0.49) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL19140901 | 0.74 | JUN (0.36) | — | |
| SCHEMBL18614890 | 0.72 | — | — | |
| SCHEMBL1797707 | 0.67 | — | — | |
| Ascorbic Acid SCHEMBL11981759 | 0.67 | MAPT (1.00) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL3700961 | 0.67 | LMNA (0.56) | LMNAMAPTL3MBTL1MANBATHRB | |
| SCHEMBL4430 | 0.67 | LMNA (0.56) | LMNAMAPTL3MBTL1MANBATHRB | |
| Ascorbic Acid SCHEMBL21114349 | 0.67 | MAPT (1.00) | LMNAMAPTL3MBTL1MANBATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3016763-B1 | A METALLIC NANOPARTICLE DISPERSION | AGFA GEVAERT (BE) | 2018-03-28 | — | — | EP | disclosed |
| US-8815954-B2 | Arginine heteromers for topical administration | REVANCE THERAPEUTICS, INC. (US) | 2014-08-26 | — | — | US | disclosed |